Shijiazhuang Pharmaceutical Group (02005.HK): It has obtained the drug production registration certificate for indobufen tablets (0.2g) from the National Medical Products Administration of China. It belongs to the third category of chemical drugs and is regarded as having passed the consistency evaluation.
